Image For Activity Cover
SSO Virtual Tumor Board: Melanoma - April 2022
Indications for neoadjuvant immunotherapy and management of nodal disease after neoadjuvant therapy.
Activity Overview

In this tumor board, the participants will hear a case-based discussion that will include:  

  1. Current evidence supporting neoadjuvant systemic therapy for surgically resectable melanoma
  2. Selection of treatment options for melanoma patients with regional disease

Moderating this session will be:

Tina J. Hieken, MD, Professor of Surgery, Mayo Clinic Cancer Center


Scott Albert, MD, St. Joseph's Health Hospital
Genevieve Boland, MD, PhD, FACS, Massachusetts General Hospital
Michael Lowe, MD, Emory University School of Medicine
Ragini Kudchadkar, MD, Emory University School of Medicine

Availability: On-Demand
Cost: Member: $0.00
Non-Member: $25.00
International Member : $0.00
International Non-Member: $25.00
Resident Member: $0.00
Resident Non-Member: $25.00
Fellow Member: $0.00
Fellow Non-Member: $25.00
Post Fellow Member: $0.00
Post Fellow Non-member: $25.00
Emeritus Member: $0.00
Emeritus International Member: $0.00
Assc Member: $0.00
Assc International Member: $0.00
Assc Non-Member: $25.00
Assc International Non-Member: $25.00
Credit Offered:
No Credit Offered
Powered By